Isolated monoclonal antibodies that bind to specific epitopes of human tissuefactor pathwayinhibitor (TFPI) and the isolated nucleic acid molecules encoding them areprovided.Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies andmethods oftreating deficiencies or defects in coagulation by administration of theantibodies are alsoprovided.